Towa Pharmaceutical Co., Ltd. (4553.T)

JPY 2808.0

(2.3%)

Revenue Summary of Towa Pharmaceutical Co., Ltd.

  • Towa Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 227.93 Billion JPY , up 9.13% from previous year.
  • Towa Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 62.56 Billion JPY , up 4.96% from previous quarter.
  • Towa Pharmaceutical Co., Ltd. reported a annual revenue of 208.85 Billion JPY in annual revenue 2022, up 26.11% from previous year.
  • Towa Pharmaceutical Co., Ltd. reported a annual revenue of 165.61 Billion JPY in annual revenue 2021, up 6.92% from previous year.
  • Towa Pharmaceutical Co., Ltd. reported a quarterly revenue of 54.54 Billion JPY for 2023 Q1, down -20.31% from previous quarter.
  • Towa Pharmaceutical Co., Ltd. reported a quarterly revenue of 227.93 Billion JPY for 2023 FY, up 9.13% from previous quarter.

Annual Revenue Chart of Towa Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual Revenue of Towa Pharmaceutical Co., Ltd. (2023 - 2004)

Year Revenue Revenue Growth
2023 227.93 Billion JPY 9.13%
2022 208.85 Billion JPY 26.11%
2021 165.61 Billion JPY 6.92%
2020 154.9 Billion JPY 40.33%
2019 110.38 Billion JPY 5.02%
2018 105.1 Billion JPY 12.49%
2017 93.43 Billion JPY 9.98%
2016 84.94 Billion JPY 3.45%
2015 82.11 Billion JPY 14.89%
2014 71.47 Billion JPY 16.49%
2013 61.35 Billion JPY 11.06%
2012 55.24 Billion JPY 13.39%
2011 48.71 Billion JPY 5.58%
2010 46.14 Billion JPY 18.19%
2009 39.04 Billion JPY 8.55%
2008 35.96 Billion JPY 14.2%
2007 31.49 Billion JPY 7.73%
2006 29.23 Billion JPY 20.84%
2005 24.19 Billion JPY -2.3%
2004 24.76 Billion JPY 0.0%

Peer Revenue Comparison of Towa Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY -266.766%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 94.654%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 27.538%
Shionogi & Co., Ltd. 435.08 Billion JPY 47.611%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY -2845.483%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY -53.745%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY -216.382%
Eisai Co., Ltd. 741.75 Billion JPY 69.271%
Morishita Jintan Co., Ltd. 12.4 Billion JPY -1737.288%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY -60.85%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY -121.542%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY -311.389%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY -641.297%
Tsumura & Co. 150.84 Billion JPY -51.105%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY -201.584%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY -317.171%
Fuji Pharma Co., Ltd. 40.88 Billion JPY -457.446%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY -201.002%
KYORIN Holdings, Inc. 119.53 Billion JPY -90.689%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY -4422.5%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY -386.052%
SymBio Pharmaceuticals Limited 5.58 Billion JPY -3977.744%
MedRx Co., Ltd 26 Million JPY -876569.231%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY -1974.063%
Solasia Pharma K.K. 617 Million JPY -36842.301%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY -262.704%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY -28.877%
Cyfuse Biomedical K.K. 61.11 Million JPY -372877.484%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 84.565%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY -929.785%